Skip to main content
Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2675
-0.0048 (-1.77%)
May 9, 2025, 9:57 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Innovative Immunotherapies for Cancer
1.93M
Log In
Log In
Log In
Log In
Innovative Immunotherapies for Cancer Growth
14.80%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States, Germany, United Kingdom and Netherlands
1.93M
Log In
Log In
Log In
Log In
United States, Germany, United Kingdom and Netherlands Growth
14.80%
Log In
Log In
Log In
Log In